Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

DANAHER CORPORATION

(DHR)
  Report
Delayed Nyse  -  04:03 2022-12-07 pm EST
268.24 USD   +1.09%
12/07Danaher Corp /de/ : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
AQ
12/06Danaher Announces Quarterly Dividends
PR
12/06Danaher Corporation Announces Quarterly Dividends, Payable on January 27, 2023
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed Nyse
12/01/2022 12/02/2022 12/05/2022 12/06/2022 12/07/2022 Date
274.54(c) 274.23(c) 267.97(c) 265.35(c) 268.24(c) Last
1 989 251 1 810 596 2 185 224 1 710 042 1 973 158 Volume
+0.41% -0.11% -2.28% -0.98% +1.09% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 30 808 M - -
Net income 2022 6 592 M - -
Net Debt 2022 12 148 M - -
P/E ratio 2022 30,9x
Yield 2022 0,38%
Sales 2023 30 737 M - -
Net income 2023 6 556 M - -
Net Debt 2023 4 758 M - -
P/E ratio 2023 31,0x
Yield 2023 0,41%
Capitalization 195 B 195 B -
EV / Sales 2022 6,73x
EV / Sales 2023 6,51x
Nbr of Employees 79 000
Free-Float 74,6%
More Financials
Company
Danaher Corporation is an industrial and technologic group organized around two families of products: - medical equipment (84.2% of net sales): diagnostic equipment, digital imaging systems, optical instruments, microscopes, consumables, etc.; - professional instruments of analysis (15.8%): systems of quality control of waters, disinfection, etc. Net sales are distributed geographically as follows: the United... 
More about the company
Ratings of Danaher Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
A
More Ratings
All news about DANAHER CORPORATION
12/07Danaher Corp /de/ : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Finan..
AQ
12/06Danaher Announces Quarterly Dividends
PR
12/06Danaher Corporation Announces Quarterly Dividends, Payable on January 27, 2023
CI
11/30Transcript : Danaher Corporation Presents at 5th Annual Evercore ISI HealthCO..
CI
11/29Insider Sell: Danaher
MT
11/29Barclays Lowers Price Target on Danaher to $277 From $285, Reiterates Overweight Rating
MT
11/22Danaher to Present at Evercore ISI HealthCONx Conference
PR
11/16Insider Sell: Danaher
MT
11/15Cepheid Launches Multiplex Vaginal Panel (MVP) to Support More Accurate Women's Health ..
PR
11/14Insider Sell: Danaher
MT
11/14Insider Sell: Danaher
MT
11/10Danaher Launches Beacon Initiative and Its First Partnership Focused on Gene Therapy In..
PR
11/10Danaher Corporation Enters Into Strategic Partnership with Duke University
CI
10/28What will the Fed do?
MS
10/28Analyst recommendations: Amazon, Apple, Caterpillar, Intel, Mast..
MS
More news
News in other languages on DANAHER CORPORATION
12/06Danaher Corporation annonce des dividendes trimestriels, payables le 27 janvier 2023
11/16Vente d'initiés : Danaher
11/14Vente d'initiés : Danaher
11/10Danaher Corporation conclut un partenariat stratégique avec l'Université Duke
10/20Danaher affiche un bénéfice ajusté et un chiffre d'affaires en hausse au 3e trimestre f..
More news
Analyst Recommendations on DANAHER CORPORATION
More recommendations
ETFs positioned on DANAHER CORPORATIONETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
Invesco Global Water ETF - USD8.6%0.00%World
Invesco Water Resources ETF - USD8.41%1.39%United_States
Nomura NEXT FUNDS International Equity MSCI...5.99%0.45%-World
The Advisors' Inner Circle Fund III Democra...4.34%-0.64%-NC
First Trust ISE Water Index Fund - USD4.21%0.65%North America
More ETFs positioned on DANAHER CORPORATION
Chart DANAHER CORPORATION
Duration : Period :
Danaher Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DANAHER CORPORATION
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 22
Last Close Price 268,24 $
Average target price 305,16 $
Spread / Average Target 13,8%
EPS Revisions
Managers and Directors
Rainer M. Blair President, Chief Executive Officer & Director
Matthew R. McGrew Chief Financial Officer & Executive Vice President
Steven M. Rales Chairman
Jose-Carlos GutiÚrrez-Ramos Chief Science Officer & Senior Vice President
Sadik Kassim Chief Technology Officer
Sector and Competitors